Northwest Biotherapeutics (NWBO) Live Share Price, Invest From India

Northwest Biotherapeutics Stock Performance

as on October 17, 2026 at 6:58 am IST

Day's Low
Day's High
$0.15
Day's Price Range
$0.16
$0.16
4.15%
Downside
2.24%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$0.16
100.00%
Downside
-100.00%
Upside

Northwest Biotherapeutics share price movements today

Previous Close: $0.15
Open: $0.16
Volume: 7.0M
Market Cap: $255.8M
Day's Low - High: $0.15 - $0.16

Northwest Biotherapeutics Historical Returns

1 Month Return: -5.44 %
3 Month Return: -7.23 %
1 Year Return: -31.66 %
3 Year Return: -76.26 %
5 Year Return: 0 %

Northwest Biotherapeutics Stock Fundamentals & Key Indicators

Check Northwest Biotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$255.8M

EPS (TTM)

-0.0249

Dividend Yield

0.00%

PE Ratio (TTM)

-6.59

Industry PE ratio

-9.69

PEG Ratio

-0.07

Return On Equity TTM

69.98%

Northwest Biotherapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Northwest Biotherapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Northwest Biotherapeutics	NA	$255.8M	NA	-6.59	-39.02%	0.00%
Moderna	Neutral	$94.4B	-32.76%	-29.64	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$128.9B	174.93%	29.37	86.04%	0.00%
Regeneron	Buy	$80.1B	42.93%	19.01	84.86%	0.46%

Stock Returns calculator for Northwest Biotherapeutics Stock including INR - Dollar returns

The Northwest Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Northwest Biotherapeutics investment value today

Current value as on today

₹73,744

Returns

-₹26,256

(-26.26%)

Returns from Northwest Biotherapeutics Stock

-₹31,659 (-31.66%)

Dollar Impact

₹5,403 (+5.4%)

Indian Investors' Interest in Northwest Biotherapeutics Stock

Search interest for Northwest Biotherapeutics Stock has increased by 95% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 18, 2026 to October 18, 2026

Change:95% versus previous 30 day period

Northwest Biotherapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2025	Jun 2025	Sep 2025	Sep 2025	Dec 2025	Dec 2025	Mar 2026	Mar 2026	Jun 2026	Jun 2026
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-14	-14	-14	-14	-13	-13	-10	-10	-11	-11
EBITDA	-13	-13	-24	-24	-12	-12	-10	-10	-10	-10
Interest Expense	1	1	2	2	2	2	2	2	1	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-15	-15	-26	-26	0	0	-3	-3	-9	-9
Income Tax Expense	-	-	-	-	0	0	-	-	-	-
Net Income	-15	-15	-26	-26	1	1	-3	-3	-9	-9
Net Profit Margin	100.00%	100.00%	-160.50%	-160.50%	-19.20%	-19.20%	-71.46%	-71.46%	-5.58%	-5.58%

Northwest Biotherapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2021	Dec 2022	Dec 2022	Dec 2023	Dec 2023	Dec 2024	Dec 2024	Dec 2025	Dec 2025
Total Revenue	1	1	1	1	1	1	1	1	1	1
Gross Profit	-19	-19	0	0	-25	-25	1	1	0	0
Operating Income	-52	-52	-67	-67	-55	-55	-66	-66	-59	-59
EBITDA	184	184	-97	-97	-55	-55	-73	-73	-49	-49
Interest Expense	5	5	6	6	5	5	7	7	-8	-8
Depreciation	0	0	1	1	1	1	2	2	2	2
Income Before Tax	179	179	-105	-105	-62	-62	-83	-83	-60	-60
Income Tax Expense	-	-	-	-	-	-	-	-	0	0
Net Income	179	179	-105	-105	-62	-62	-83	-83	-61	-61
Net Profit Margin	-1920.70%	-1920.70%	8.02%	8.02%	-1335.30%	-1335.30%	100.00%	100.00%	-69.59%	-69.59%

Northwest Biotherapeutics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2025	Jun 2025	Sep 2025	Sep 2025	Dec 2025	Dec 2025	Mar 2026	Mar 2026	Jun 2026	Jun 2026
Net Income	-15	-15	-26	-26	1	1	-3	-3	-8	-8
Operating Cash Flow	-6	-6	-13	-13	-14	-14	-12	-12	-7	-7
Investing Cash Flow	0	0	0	0	0	0	0	0	0	0
Financing Cash Flow	12	12	11	11	13	13	9	9	7	7
Change in Cash	1	1	0	0	-1	-1	-1	-1	-1	-1

Northwest Biotherapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2021	Dec 2022	Dec 2022	Dec 2023	Dec 2023	Dec 2024	Dec 2024	Dec 2025	Dec 2025
Net Income	179	179	-105	-105	-62	-62	-83	-83	-60	-60
Operating Cash Flow	-38	-38	-52	-52	-53	-53	-57	-57	-44	-44
Investing Cash Flow	-6	-6	-2	-2	-3	-3	-1	-1	-1	-1
Financing Cash Flow	48	48	41	41	52	52	56	56	49	49
Change in Cash	5	5	-8	-8	-4	-4	0	0	0	0

Insights on Northwest Biotherapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 494.0K → 807.0K (in $), with an average increase of 38.8% per quarter
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 769.9%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 152.5% return, outperforming this stock by 228.8%
NEGATIVE IMPACT
Price Dip
In the last 3 years, NWBO stock has moved down by -76.3%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 1.38M → -9.22M (in $), with an average decrease of 260.8% per quarter

About Northwest Biotherapeutics

Northwest Biotherapeutics, Inc. (NWBO) is a biotechnology firm that creates personalized immune-based treatments for various cancers, operating both within the United States and internationally. Their product pipeline relies on DCVax, a proprietary technology platform. This platform harnesses a patient's own activated dendritic cells to stimulate their immune system to combat cancerous cells. The company's leading therapeutic candidate, DCVax-L, has successfully completed Phase III clinical trials targeting Glioblastoma multiforme, an aggressive form of brain cancer. Additionally, Northwest Biotherapeutics is progressing DCVax-Direct through Phase I/II clinical studies, focusing on the treatment of inoperable solid tumors. Founded in 1996, the company's headquarters are situated in Bethesda, Maryland.

Organisation	Northwest Biotherapeutics
Headquarters	4800 Montgomery Lane, Bethesda, MD, 20814, US
Industry	Biotechnology
CEO	Linda F. Powers

Key Management of Northwest Biotherapeutics

Name	Title
Ms. Linda F. Powers J.D.	Chairperson, CEO, President, CFO & Chief Accounting Officer
Dr. Alton L. Boynton Ph.D.	Founder, Chief Scientific Officer, Secretary & Director
Dr. Marnix L. Bosch M.B.A., Ph.D.	Chief Technical Officer
Mr. David Innes	Vice President of Investor Relations

FAQs

What is Northwest Biotherapeutics share price today?

Northwest Biotherapeutics share price today is $0.16 as on October 17, 2026 at 1:28 am IST at the close of the market. Northwest Biotherapeutics share today touched a day high of $0.16 and a low of $0.15.

What is the 52 week high and 52 week low for Northwest Biotherapeutics share?

Northwest Biotherapeutics share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Northwest Biotherapeutics stock price today i.e. October 17, 2026 at 1:28 am IST is closed at $0.16,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Northwest Biotherapeutics's market capitalisation today?

Northwest Biotherapeutics market capitalisation is $0.00T as on October 17, 2026 at 1:28 am IST.

How to invest in Northwest Biotherapeutics Stock (NWBO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Northwest Biotherapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Northwest Biotherapeutics Stock (NWBO) from India?

Indian investors can start investing in Northwest Biotherapeutics (NWBO) shares with as little as ₹94.95999908447266 or $1 (as of October 18, 2026 at 2:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Northwest Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on October 18, 2026 at 2:38 am IST). Based on Northwest Biotherapeutics share’s latest price of $0.16 as on October 17, 2026 at 1:28 am IST, you will get 63.8978 shares of Northwest Biotherapeutics. Learn more about fractional shares .